The impact and challenges of Covid-19 on patients with rare and undiagnosed disease

As the Covid-19 pandemic stretches on, patients with rare and undiagnosed diseases (RUDs) are increasingly enduring significant health challenges. A recent study by Halley et al. (2020) found, that there are certain impacts the pandemic has on RUDs, stressing the importance of the improvement and support of easy healthcare access.

At Nostos Genomics we are proud to support the diagnosis of patients with rare disease

Read the paper on the effect of Covid-19 on RUDs below.

https://www.nature.com/articles/s41436-020-01069-7